Cargando…
Adalimumab/methotrexate/prednisone: Severe COVID-19 infection: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787632/ http://dx.doi.org/10.1007/s40278-021-87847-1 |
Ejemplares similares
-
Adalimumab/methotrexate: COVID-19 infection: case report
Publicado: (2020) -
Adalimumab/prednisone: Mycobacterium chelonae infection: case report
Publicado: (2021) -
Methotrexate/prednisone: COVID-19 pneumonia: case report
Publicado: (2021) -
Methotrexate/prednisone/rituximab: COVID-19 pneumonia: 3 case reports
Publicado: (2021) -
Favorable outcome of COVID-19 in a young woman with severe Crohn’s disease on regular use of adalimumab and prednisone: a case report
por: Vechi, Hareton Teixeira, et al.
Publicado: (2020)